Cizzle Bio Launches CIZ1B Biomarker Blood Test for Early Lung Cancer

Now Available to Health Care Providers in Dallas-Fort Worth and San Antonio DALLAS, July 22, 2026 /PRNewswire/ -- Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests ...
Rutland Herald

A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation

HONG KONG SAR - Media OutReach Newswire - 22 July 2026 - Gene Solutions – a global biotechnology company advancing accessible ...
Vietnam Investment Review on MSN

Gene Solutions SPOT MAS wins FDA Breakthrough Device status

HONG KONG SAR - Media OutReach Newswire - 22 July 2026 - Gene Solutions – a global biotechnology company advancing accessible genomic solutions for cancer detection and precision oncology, announced ...

Testing innovation speeds up detection of deadly tick-borne disease

A new method at the University of Missouri could transform how Rocky Mountain spotted fever is diagnosed. The method detects ...